United Therapeutics Insider Sold Shares Worth $5,219,015, According to a Recent SEC Filing

MT newswire2026/10/05 20:58

04:58 PM EDT, 10/05/2026 (MT Newswires) -- Martine A Rothblatt, Director, Chairperson & CEO, on October 02, 2026, sold 9,500 shares in United Therapeutics (UTHR) for $5,219,015. Following the Form 4 filing with the SEC, Rothblatt has control over a total of 668,728 common shares of the company, with 40,513 shares held directly and 628,215 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1082554/000110657826000156/xslF345X05/primarydocument.xml

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

You may also like

Circle discloses USDC operational data for the first half of 2026, with revenue of approximately $1.4 billion.

AiCoin•2026/10/16 12:43

BUZZ-Concentra shares rise; Jefferies initiates with “Buy” rating

路透社•2026/10/16 12:42

BUZZ-Strategy shares fall after MSCI warns it may be removed from global indices

路透社•2026/10/16 12:37

Chart: As Treasury yields fall, US equity funds attract inflows again

路透社•2026/10/16 12:37